Steward Partners Investment Advisory LLC lifted its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 17.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,269 shares of the company’s stock after acquiring an additional 332 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in Doximity were worth $121,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Plato Investment Management Ltd bought a new stake in Doximity during the 4th quarter valued at about $207,000. SBI Securities Co. Ltd. bought a new stake in Doximity during the 4th quarter valued at about $4,207,000. West Michigan Advisors LLC purchased a new position in Doximity during the 4th quarter valued at about $306,000. US Bancorp DE increased its position in Doximity by 7.8% during the 4th quarter. US Bancorp DE now owns 11,285 shares of the company’s stock valued at $603,000 after purchasing an additional 818 shares during the period. Finally, Fielder Capital Group LLC increased its position in Doximity by 4.5% during the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after purchasing an additional 235 shares during the period. Institutional investors own 87.19% of the company’s stock.
Doximity Trading Up 4.2 %
Shares of NASDAQ DOCS opened at $63.33 on Monday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a 50 day simple moving average of $63.63 and a two-hundred day simple moving average of $52.72. The stock has a market cap of $11.82 billion, a price-to-earnings ratio of 63.33, a PEG ratio of 4.10 and a beta of 1.34.
Insider Activity at Doximity
Wall Street Analyst Weigh In
A number of research analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a research report on Thursday, November 21st. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Piper Sandler raised shares of Doximity from a “neutral” rating to an “overweight” rating and raised their target price for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Stephens assumed coverage on shares of Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 target price on the stock. Finally, Raymond James reissued an “outperform” rating and set a $83.00 target price (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Doximity presently has a consensus rating of “Moderate Buy” and an average price target of $64.22.
Read Our Latest Report on Doximity
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
- Five stocks we like better than Doximity
- How Investors Can Find the Best Cheap Dividend Stocks
- How to Build the Ultimate Everything ETF Portfolio
- How to Buy Cheap Stocks Step by Step
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Breakout Stocks: What They Are and How to Identify Them
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.